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Background
The term candiduria can be defined as the observation of
yeasts on direct examination of urine through the presence
of pseudo-hyphae and fungal growth in urine culture [1].
The yeast Candiduria can be detected in the urine in
patients who have bladder colonization and in patients
who have urinary tract infection [2]. Currently, there are
few options in the medicine antifungal market for the
treatment of urinary tract infections. And the most
used are amphotericin B, ketoconazole, fluconazole and
voriconazole. Therefore, the determination of the profile
of antifungal susceptibility among isolates of C. albicans
urine in patients, it is so important as epidemiological
marker that serves to guide therapeutic procedures [3].
Thus, many methods have been tested as alternative to
the antifungal susceptibility, as the method of agar disk
diffusion M44-A12. So, this study aimed to evaluate the
antifungal susceptibility profile of Candida albicans iso-
lated from the urine of patients admitted at the university
hospital in Dourados - MS.
Methods
In this study we used 24 samples of Candida albicans
from urine cultures of patients hospitalized at the univer-
sity hospital of Grande Dourados, from June 2010 to June
2012. The yeasts were isolated and identified according to
the conventional method. The antifungal susceptibility of
isolates of Candida albicans was evaluated using the disk-
agar diffusion method, according to the standards of the
Clinical and Laboratory Standards Institute (CLSI) M-44
[4], using as antifungal fluconazole and voriconazole. The
tests were performed in duplicate and the reading of the
plates was performed using the methodology described by
Demitto, 2012 [5].
Results and conclusions
The results obtained in testing susceptibility to the anti-
fungal fluconazole showed that 54.16% of the samples
were sensitive and 45.83% were resistant to the same drug.
The antifungal voriconazole showed that 54.16% of strains
were sensitive and 45.83% were resistance to the same
drug. According to the results obtained by Demito et al.
2012, the antibiotics fluconazole and voriconazole showed
equivalent efficacy in vitro. So, this maybe can be related
to cross-resistance due to the similarity of the chemical
structure of these azoles, because strains resistant to fluco-
nazole also showed resistance to voriconazole.
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